Selective reporting biases in cancer prognostic factor studies

被引:184
作者
Kyzas, PA
Loizou, KT
Ioannidis, JPA [1 ]
机构
[1] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin & Mol Epidemiol Unit, GR-45110 Ioannina, Greece
[2] Fdn Res & Technol Hellas, Biomed Res Inst, Ioannina, Greece
[3] Tufts Univ, New England Med Ctr, Inst Clin Res & Hlth Policy Studies, Dept Med, Boston, MA 02111 USA
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2005年 / 97卷 / 14期
关键词
D O I
10.1093/jnci/dji184
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Nonreported and selectively reported information and the use of different definitions may introduce biases in the literature of prognostic factors. We probed these biases in a meta-analysis of a prognostic factor for head and neck squamous cell cancer (HNSCC) mortality that has drawn wide attention-the status of the tumor suppressor protein TP53. Methods: We compared results of meta-analyses that included published data plus unpublished data retrieved from investigators; published data; and only published data indexed with "survival" or "mortality" in MEDLINE/EMBASE, with or without standardized definitions. We also evaluated whether previously published meta-analyses on mortality predictors for various malignancies addressed issues of retrieval and standardized information. All statistical tests were two-sided. Results: For the 18 studies with 1364 patients that included published and indexed data, we obtained a highly statistically significant association between TP53 status and mortality. When we used the definitions preferred by each publication, the association was stronger (risk ratio [RR] = 1.38, 95% confidence interval [CI] = 1.13 to 1.67; P =.001) than when we standardized definitions (RR = 1.27, 95% CI = 1.06 to 1.53; P =.011). The addition of 13 studies with 1028 subjects that included published but not indexed data reduced the observed association (RR = 1.23, 95% CI = 1.03 to 1.47; P =.02). Finally, when we obtained data from investigators (11 studies with 996 patients) and analyzed it with all other data, statistical significance was lost (RR = 1.16, 95% CI = 0.99 to 1.35; P =.06). Among 18 published meta-analyses of 37 cancer prognostic factors, 13 (72%) did not use standardized definitions and 16 (89%) did not retrieve additional information. Conclusions: Selective reporting may spuriously inflate the importance of postulated prognostic factors for various malignancies. We recommend that meta-analyses thereof should maximize retrieval of information and standardize definitions.
引用
收藏
页码:1043 / 1055
页数:13
相关论文
共 135 条
[71]   Summing up evidence: one answer is not always enough [J].
Lau, J ;
Ioannidis, JPA ;
Schmid, CH .
LANCET, 1998, 351 (9096) :123-127
[72]   Quantitative synthesis in systematic reviews [J].
Lau, J ;
Ioannidis, JPA ;
Schmid, CH .
ANNALS OF INTERNAL MEDICINE, 1997, 127 (09) :820-826
[73]   TUMOR ANGIOGENESIS, THE P53 ANTIGEN, AND CERVICAL METASTASIS IN SQUAMOUS-CELL CARCINOMA OF THE TONGUE [J].
LEEDY, DA ;
TRUNE, DR ;
KRONZ, JD ;
WEIDNER, N ;
COHEN, JI .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1994, 111 (04) :417-422
[74]  
Lera J, 1998, CANCER, V83, P2493, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2493::AID-CNCR13>3.3.CO
[75]  
2-3
[76]   Clinical implication of screening p53 gene mutations in head and neck squamous cell carcinomas [J].
Ma, L ;
Ronai, A ;
Riede, UN ;
Kohler, G .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1998, 124 (07) :389-396
[77]   A comparison of methods to detect publication bias in meta-analysis [J].
Macaskill, P ;
Walter, SD ;
Irwig, L .
STATISTICS IN MEDICINE, 2001, 20 (04) :641-654
[78]   Expression of vascular endothelial growth factor in human oral squamous cell carcinoma: its association with tumour progression and p53 gene status [J].
Maeda, T ;
Matsumura, S ;
Hiranuma, H ;
Jikko, A ;
Furukawa, S ;
Ishida, T ;
Fuchihata, H .
JOURNAL OF CLINICAL PATHOLOGY, 1998, 51 (10) :771-775
[79]   Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis [J].
Martin, B ;
Paesmans, M ;
Berghmans, T ;
Branle, F ;
Ghisdal, L ;
Mascaux, C ;
Meert, AP ;
Steels, E ;
Vallot, F ;
Verdebout, JM ;
Lafitte, JJ ;
Sculier, JP .
BRITISH JOURNAL OF CANCER, 2003, 89 (01) :55-64
[80]   The role of HER-2/neu expression on the survival of patients with lung cancer: a systematic review of the literature [J].
Meert, AP ;
Martin, B ;
Paesmans, M ;
Berghmans, T ;
Mascaux, C ;
Verdebout, JM ;
Delmotte, P ;
Lafitte, JJ ;
Sculier, JP .
BRITISH JOURNAL OF CANCER, 2003, 89 (06) :959-965